Cargando…

C-reactive protein in aortic valve disease

Aortic Valve Disease, includes a range of disorder severity from mild leaflet thickening without valve obstruction, "aortic sclerosis", to severe calcified aortic stenosis. It is a slowly progressive active process of valve modification similar atherosclerosis for cardiovascular risk facto...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanchez, Pedro L, Mazzone, Anna Maria
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1618858/
https://www.ncbi.nlm.nih.gov/pubmed/17042945
http://dx.doi.org/10.1186/1476-7120-4-37
_version_ 1782130534613254144
author Sanchez, Pedro L
Mazzone, Anna Maria
author_facet Sanchez, Pedro L
Mazzone, Anna Maria
author_sort Sanchez, Pedro L
collection PubMed
description Aortic Valve Disease, includes a range of disorder severity from mild leaflet thickening without valve obstruction, "aortic sclerosis", to severe calcified aortic stenosis. It is a slowly progressive active process of valve modification similar atherosclerosis for cardiovascular risk factors, lipoprotein deposition, chronic inflammation, and calcification. Systemic signs of inflammation, as wall and serum CRP, similar to those found in atherosclerosis, are present in patients with degenerative aortic valve stenosis and may be expression of a common disease, useful in monitoring of stenosis progression.
format Text
id pubmed-1618858
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-16188582006-10-21 C-reactive protein in aortic valve disease Sanchez, Pedro L Mazzone, Anna Maria Cardiovasc Ultrasound Review Aortic Valve Disease, includes a range of disorder severity from mild leaflet thickening without valve obstruction, "aortic sclerosis", to severe calcified aortic stenosis. It is a slowly progressive active process of valve modification similar atherosclerosis for cardiovascular risk factors, lipoprotein deposition, chronic inflammation, and calcification. Systemic signs of inflammation, as wall and serum CRP, similar to those found in atherosclerosis, are present in patients with degenerative aortic valve stenosis and may be expression of a common disease, useful in monitoring of stenosis progression. BioMed Central 2006-10-16 /pmc/articles/PMC1618858/ /pubmed/17042945 http://dx.doi.org/10.1186/1476-7120-4-37 Text en Copyright © 2006 Sanchez and Mazzone; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Sanchez, Pedro L
Mazzone, Anna Maria
C-reactive protein in aortic valve disease
title C-reactive protein in aortic valve disease
title_full C-reactive protein in aortic valve disease
title_fullStr C-reactive protein in aortic valve disease
title_full_unstemmed C-reactive protein in aortic valve disease
title_short C-reactive protein in aortic valve disease
title_sort c-reactive protein in aortic valve disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1618858/
https://www.ncbi.nlm.nih.gov/pubmed/17042945
http://dx.doi.org/10.1186/1476-7120-4-37
work_keys_str_mv AT sanchezpedrol creactiveproteininaorticvalvedisease
AT mazzoneannamaria creactiveproteininaorticvalvedisease